Antioxidant status of Mauritian subjects with type II diabetes mellitus

Author： Neergheen-Bhujun Vidushi   Rosun Halimah   Joonas Noorjehan   Bahorun Theeshan  

Publisher： Springer Publishing Company

ISSN： 0973-3930

Source： International Journal of Diabetes in Developing Countries, Vol.33, Iss.3, 2013-09, pp. : 161-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current Status and Prospects for Gene and Cell Therapeutics for Type 1 Diabetes Mellitus

By Giannoukakis Nick   Trucco Massimo  

Reviews in Endocrine and Metabolic Disorders, Vol. 4, Iss. 4, 2003-12 ,pp. : 369-380

Springer Publishing Company

Access to resources Recommend Favorite

Underlying Pathways for Interferon Risk to Type II Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 9, Iss. 6, 2013-11 ,pp. : 472-477

Bentham Science Publishers

Access to resources Recommend Favorite

Alogliptin: a Novel Molecule for Improving Glycemic Control in Type II Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 6, Iss. 6, 2010-11 ,pp. : 410-421

Bentham Science Publishers

Access to resources Recommend Favorite

Coagulation status in coronary artery disease patients with type II diabetes mellitus compared with non-diabetic coronary artery disease patients using the PFA-100® and ROTEM®

By Feuring M.   Wehling M.   Burkhardt H.   Schultz A.  

Platelets, Vol. 21, Iss. 8, 2010-12 ,pp. : 616-622

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus

By Zheng Xiaoya  

Acta Diabetologica, Vol. 47, Iss. 3, 2010-09 ,pp. : 265-270

Springer Publishing Company

Access to resources Recommend Favorite